Important poisonous plants in Tibetan ethnomedicine

Toxins

Volumn 7, Issue 1, 2015, Pages 138-155

  Ma, Lijuan ^a   Gu, Ronghui ^a   Tang, Li ^a   Chen, Ze E ^a   Di, Rong ^b   Long, Chunlin ^a,c  

^a MINZU UNIVERSITY OF CHINA   (China)

^b RUTGERS UNIVERSITY   (United States)

^c KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Aconitine; Anisodamine; Poisonous plants; Scopolamine; Strychnine; Tibetan ethnomedicine; Toxins

Indexed keywords

10,11 DIMETHOXY 4 N HYDROXYMETHYL STRYCHNIDIN 17 ACETIC ACID; 2 HYDROXY 3 METHOXYSTRYCHNINE; 4 N HYDROXYMETHYL STRYCHNIDIN 17 ACETIC ACID; ACONITINE; ACONITUM EXTRACT; AJMALINE; ALKALOID; ANALGESIC AGENT; ANESTHETIC AGENT; ANISODAMINE; ANISODUS TANGUTICUS EXTRACT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTINOCICEPTIVE AGENT; ANTIRHEUMATIC AGENT; BRUCINE; CARDIOVASCULAR AGENT; DATURA STRAMONIUM EXTRACT; FLAVANOID; GLYCOSIDE; ISOBRUCINE; ISOSTRYCHNINE N OXIDE; PLANT EXTRACT; SCOPOLAMINE; SESQUITERPENE; STEROID; STRYCHNINE; STRYCHNOS NUX VOMICA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WITHANOLIDE; PLANT MEDICINAL PRODUCT;

ACONITE; ACONITUM PENDULUM; ANGIOGENESIS; ANISODUS TANGUTICUS; ANTICONVULSANT ACTIVITY; ANTINOCICEPTION; ARTICLE; COGNITIVE DEFECT; DATURA STRAMONIUM; MEDICINAL PLANT; POISONOUS PLANT; SODIUM TRANSPORT; STRYCHNOS NUX VOMICA; TIBETAN MEDICINE; ANIMAL; CHEMISTRY; HUMAN; SOLANACEAE; STRYCHNOS; TIBET; TOXICITY; TRADITIONAL MEDICINE;

ACONITUM PENDULUM; ANISODUS TANGUTICUS; DATURA STRAMONIUM; STRYCHNOS NUX-VOMICA; STRYCHNOS TOXIFERA;

ACONITUM; ANIMALS; HUMANS; MEDICINE, TRADITIONAL; PHYTOCHEMICALS; PLANTS, TOXIC; SOLANACEAE; STRYCHNOS; TIBET;

EID: 84921760512     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins7010138     Document Type: Article

References (84)

1. Salick, J.; Byg, A.; Amend, A.; Gunn, B.; Law, W.; Schmidt, H. Tibetan medicine plurality. Econ. Bot. 2006, 60, 227-253.
2. Pordié, L. Tibetan medicine today: Neo-traditionalism as an analytical lens and a political tool. In Tibetan Medicine in the Contemporary World. Global Politics of Medical Knowledge and Practice; Pordié, L., Ed.; Routledge: London, UK; New York, NY, USA, 2010; pp. 3-32.
3. Di Sarsina, P.R.; Ottaviani, L.; Mella, J. Tibetan medicine: A unique heritage of person-centered medicine. EPMA J. 2011, 2, 358-389.
4. Tenzing Pengcuo, D. Jingzhu Materia Medica (Jing Zhu Ben Cao, Chinese Version); Shanghai Science and Technology Press: Shanghai, China, 2012; pp. 52-144, Translated by Mao, J.; Luo, D.; Wang, Z.; Ma, S.
5. Yang, J.S. Diqing Zangyao (Diqing Medicinal Plants); Yunnan Sci & Tech Press: Kunming, China, 1989; pp. 10-133.
6. Zhang, Q.R.; Xia, G.C. Color Pictorial Handbook of Toxic Chinese Herbs; Tianjin Sci & Tech Translation Publishing Co.: Tianjin, China, 1996; pp. 13-225.
7. Li, L.Q.; Kadota, Y. Actonitum. In Flora of China; Wu, Z.Y., Raven, P., Eds.; Science Press, and Missouri Botanical Garden Press: Beijing, China; St. Louis, MO, USA, 2001; pp. 149-222.
8. Yang, Q.E. Taxonomic notes on some species of Aconitum L. (Ranunculaceae) from Yunnan, China. J. Syst. Evol. 1999, 37, 545-590.
9. Luo, Y.; Yang, Q.E. Taxonomic revision of Aconitum (Ranunculaceae) from Sichuan, China. J. Syst. Evol. 2005, 43, 289-386.
10. Kang, Y.X.; Uczaj, J.; Ye, S. The highly toxic Aconitum carmichaelii Debeaux as a root vegetable in the Qinling Mountains (Shaanxi, China). Genet. Resour. Crop Evol. 2012, 59, 1569-1575.
11. Chan, T.Y.K. Aconitum alkaloid poisoning related to the culinary uses of aconite roots. Toxins 2014, 6, 2605-2611.
12. Xiao, P.G.; Wang, F.P.; Gao, F.; Yan, L.P.; Chen, D.P.; Liu, Y. A pharmacophylogenetic study of Aconitum L. (Ranunculaceae) from China. J. Syst. Evol. 2006, 44, 1-46.
13. Li, B.T.; Leeuwenberg, A.J.M. Loganiaceae. In Flora of China; Wu, Z.Y., Raven, P., Eds.; Science Press, and Missouri Botanical Garden Press: Beijing, China; St. Louis, MO, USA, 2001; pp. 320-327.
14. Ma, Y.P. Method improvement of stir-frying with sands for processing Semen Strychni. China J. Chin. Mater. Med. 2002, 27, 712.
15. Zhang, Z.Y.; Lu, A.M.; D’Arcy, W.G. Solanaceae. In Flora of China; Wu, Z.Y., Raven, P., Eds.; Science Press, and Missouri Botanical Garden Press: Beijing, China; St. Louis, MO, USA, 1994; Volume 17, pp. 300-332.
16. Liu, Y.L.; Chen, T.; Chen, C.; Zou, D.L.; Li, Y.L. Isolation and preparation of an imidazole alkaloid from radix of Aconitum pendulum Busch by semi-preparative high-speed counter-current chromatography. Se Pu 2014, 32, 543-546.
17. Wang, Y.J.; Zhang, J.; Zeng, C.J.; Yao, Z.; Zhang, Y. Three new C19-diterpenoid alkaloids from Aconitum pendulum. Phytochem. Lett. 2011, 4, 166-169.
18. Wang, Y.J.; Zeng, C.J.; Yao, Z.; Zhang, J.; Zhang, Y.; Zhang, F. Diterpene alkaloids from roots and processed products of Aconitum pendulum. Zhong Cao Yao 2010, 41, 347-351.
19. Zhang, S.M.; Tan, L.Q.; Ou, Q.Y. Diterpenoid alkaloids from Aconitum pendulum. Chin. Chem. Lett. 1997, 8, 967-970.
20. Liu, L.M.; Wang, H.C.; Zhu, Y.L. Studies on Chinese drug Aconitum spp. XIX the alkaloids of Aconitum pendulum and their chemical structure. Yao Xue Xue Bao 1983, 18, 39-44.
21. Cai, B.C.; Hattori, M.; Namba, T. Processing of nux vomica. Changes in alkaloid composition of the seeds of Strychnos nux-vomica L. on traditional drug-processing. Chem. Pharm. Bull. 1990, 38, 1295-1298.
22. Zhang, X.Z.; Xu, Q.; Xiao, H.B.; Liang, X.M. Iridoid glucosides from Strychnos nux-vomica. Phytochemistry 2003, 64, 1341-1344.
23. Frederich, M.; Choi, Y.H.; Angenot, L.; Harnischfeger, G.; Lefeber, A.W.M.; Verpoorte, R. Metabolomic analysis of Strychnos nux-vomica, Strychnos icaja and Strychnos ignatii extracts by 1H nuclear magnetic resonance spectrometry and multivariate analysis techniques. Phytochemistry 2004, 65, 1993-2001.
24. Kuang, H.X.; Yang, B.Y.; Xia, Y.G.; Feng, W.S. Chemical constituents from the flower of Datura metel L. Arch. Pharm. Res. 2008, 31, 1094-1097.
25. Yang, B.Y.; Xia, Y.G.; Wang, Q.H.; Dou, D.Q.; Kuang, H.X. Two new amide alkaloids from the flower of Datura metel L. Fitoterapia 2010, 81, 1003-1005.
26. Pan, Y.H.; Wang, X.H.; Hu, X.M. Cytotoxic Withanolides from the flowers of Datura metel. J. Nat. Prod. 2007, 70, 1127-1132.
27. Ma, L.; Xie, C.M.; Li, J.; Lou, F.C.; Hu, L.H. Daturametelins H, I and J: Three new withanolide glycosides from Datura metel L. Chem. Biodivers. 2006, 3, 180.
28. Poupko, J.M.; Baskin, S.I.; Moore, E. The pharmacological properties of anisodamine. J. Appl. Toxicol. 2007, 27, 116-121.
29. Yang, S.; Yang, X.D.; Zhao, J.F.; Jin, Y.; Zhang, H.B.; Li, L. A new C19-diterpenoid alkaloid, habaenine C, from Aconitum habaense. Chem. Nat. Compd. 2008, 44, 334-336.
30. Xue, J.; Yang, C.H.; Liu, J.H.; Liang, J.Y.; Tang, Q.F.; Zhang, S.J. Recent advance of diterpenoid alkaloids in genus Aconitum. Strait Pharmaceut. J. 2009, 21, 1-10.
31. Ameri, A. The effects of Aconitum alkaloids on the central nervous system. Prog. Neurobiol. 1998, 56, 211-235.
32. Isono, T.; Oyama, T.; Asami, A.; Suzuki, Y.; Hayakawa, Y.; Ikeda, Y.; Noguchi, M.; Omiya, Y. The analgesic mechanism of processed aconitie tuber: The involvement of the descending inhibitory system. Am. J. Chin. Med. 1994, 22, 83-94.
33. Bisset, N.G.; Phillipson, J.D. The tertiary alkaloids of some Asian species of Strychnos. J. Pharm. Pharmacol. 1971, 23, 244S.
34. Makarovsky, I.; Markel, G.; Hoffman, A.; Schein, O.; Broshnissimov, T.; Tashma, Z.; Dushnitsky, T.E.A. Strychnine-a killer from the past. Isr. Med. Assoc. J. 2008, 10, 142-145.
35. Cai, B.C.; Yang, W.X.; Zhu, W.Y.; Lu, J.C.; Ye, D.J. Effect of processing on the extraction of alkaloids from Strychnos. Zhong Cao Yao 1993, 18, 23-24.
36. Yin, W.; Wang, T.; Yin, F.; Cai, B. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. J. Ethnopharmacol. 2003, 88, 205-214.
37. 13CNMR of sixteen Strychnos alkaloids. Yao Xue Xue Bao 1994, 29, 44-48.
38. Yang, X.W.; Yan, Z.K.; Cai, B.C. Studies on the chemical constituents of alkaloids in seeds of Strychnos nux-vomica L. Zhongguo Zhong Yao Za Zhi 1993, 18, 739-740.
39. Liu, X.K.; Li, W. Chemical constituents of Maqianzi (Strychno nux-vomica). Zhong Cao Yao 1998, 29, 435-438.
40. Yang, G.M.; Tu, X.; Liu, L.J.; Pan, Y. Two new bisindole alkaloids from the seeds of Strychnos nux-vomica. Fitoterapia 2010, 81, 932-936.
41. China Pharmacopoeia Commission. Pharmacopoeia of China; Chemical Industry Press: Beijing, China, 2005; Volume 1, p. 188.
42. Berkov, S.; Zayed, R.; Doncheva, T. Alkaloid patterns in some varieties of Datura stramonium. Fitoterapia 2006, 77, 179-182.
43. Barene, I.A.; Minina, S.A. Alkaloid of the roots of Seopolia tangutiea. Chem. Nat. Compd. 1971, 3, 360-361.
44. Ameri, A.; Gleitz, J.; Peters, T. Inhibition of neuronal activity in rat hippocampal slices by Aconitum alkaloids. Brain Res. 1996, 738, 154-157.
45. Nyirimigabo, E.; Xu, Y.Y.; Li, Y.B.; Wang, Y.M.; Agyemang, K.; Zhang, Y.J. A review on phytochemistry, pharmacology and toxicology studies of Aconitum. J. Pharm. Pharmacol. 2014, 67, 1-19.
46. Catterall, W.A. Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu. Rev. Pharmacol. Toxicol. 1980, 20, 15-43.
47. Gutser, U.T.; Friese, J.; Heubach, J.F.; Matthiesen, T.; Selve, N.; Wilffert, B.; Gleitz, J. Mode of antinociceptive and toxic action of alkaloids of Aconitum species. Naunyn Schmiedebergs Arch. Pharmacol. 1998, 357, 39-48.
48. Chan, T.Y.K. Aconitum alkaloid content and the high toxicity of aconite tincture. Forensic Sci. Int. 2012, 222, 1-3.
49. Chan, T.Y.K. Aconite poisoning following the percutaneous absorption of Aconitum alkaloids. Forensic Sci. Int. 2012, 223, 25-27.
50. Deng, X.K.; Wu, Y.; Li, W.D.; Yin, F.Z.; Lu, X.Y.; Zhang, X.C.; Hua, Z.C.; Cai, B.C. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. J. Ethnopharmacol. 2006, 106, 179-186.
51. Yin, W.; Deng, X.K.; Yin, F.Z.; Zhang, X.C.; Cai, B.C. The cytotoxicity induced by brucine from the seed of Strychnos nux-vomica proceeds via apoptosis and is mediated by cyclooxygenase 2 and caspase 3 in SMMC 7221 cells. Food Chem. Toxicol. 2007, 45, 1700-1708.
52. Rao, P.S.; Ramanadham, M.; Prasad, M.N.V. Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line C RPMI 8226. Food Chem. Toxicol. 2009, 47, 283-288.
53. Saraswati, S.; Agarwal, S.S. Strychnine inhibits inflammatory angiogenesis in mice via down regulation of VEGF, TNF-α and TGF-β. Microvasc. Res. 2013, 87, 7-13.
54. Li, Y.; Qi, X.; Yang, Y.; Pan, Y.; Bian, H. Toxic effects of strychnine and strychnine N-oxide on zebrafish embryos. Chin. J. Nat. Med. 2014, 12, 760.
55. Philippe, G.; Angenot, L.; Tits, M.; Frederich, M. About the toxicity of some Strychnos species and their alkaloids. Toxicon 2004, 44, 405-416.
56. Xiang, X.H.; Wang, H.L.; Wu, W.R.; Guo, Y.; Cao, D.Y.; Wang, H.S.; Zhao, Y. Ethological analysis of scopolamine treatment or pretreatment in morphine dependent rats. Physiol. Behav. 2006, 88, 183-189.
57. Zayed, R.; Wink, M. Induction of tropane alkaloid formation in transformed root cultures of Brugmansia suaveolens(Solanaceae). Z. Naturforsch. C Biosci. 2004, 59c, 863-886.
58. Ebert, U.; Kirch, W. Scopolamine model of dementia: Electroencephalogram findings and cognitive performance. Eur. J. Clin. Investig. 1998, 28, 944-949.
59. Klinkenberg, I.; Blokland, A. The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neurosci. Biobehav. Rev. 2010, 34, 1307-1350.
60. Drachman, D.A.; Leavitt, J. Human memory and the cholinergic system: A relationship to aging? Arch. Neurol. 1974, 30, 113-121.
61. Budzynska, B.; Boguszewska-Czubara, A.; Kruk-Slomka, M.; Skalicka-Wozniak, K.; Michalak, A.; Musik, I.; Biala, G. Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice. Psychopharmacology 2014, doi:10.1007/s00213-014-3728-6.
62. Szczodry, O.; van der Staay, F.J.; Arndt, S.S. Modelling Alzheimer-like cognitive deficits in rats using biperiden as putative cognition impairer. Behav. Brain Res. 2014, 274, 307-311.
63. Almasi-Nasrabadi, M.; Gharedaghi, M.H.; Rezazadeh, P.; Dehpour, A.R.; Javadi-Paydar, M. NMDA receptors interact with the retrieval memory enhancing effect of pioglitazone in mice. Pharmacol. Biochem. Behav. 2014, 126, 136-145.
64. English, B.A.; Osimo, N.; Korb, A.; Bazih, A.; Rodriguez, C.; Sotomayor, B.; Gertsik, L.; Ereshefsky, L. Effects of scopolamine on working memory task and resting functional connectivity using FMRI in healthy Korean subjects. Alzheimers Dement. 2014, 10, S919.
65. Lee, B.; Sur, B.; Shim, J.; Hahm, D.H.; Lee, H. Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats. BMC Complem. Altern. Med. 2014, 14, 338.
66. Jones, D.N.C.; Higgins, G.A. Effect of scopolamine on visual attention in rats. Psychopharmacology 1995, 120, 142-149.
67. Tobin, G.; Giglio, D.; Gtrick, B. Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Auton. Neurosci. 2002, 100, 1-9.
68. Dringenberg, H.C.; Vanderwolf, C.H. Neocortical activation: Modulation by multiple pathways acting on central cholinergic and serotonergic systems. Exp. Brain Res. 1997, 116, 160-174.
69. Rodriguez, R.; Kallenbach, U.; Singer, W.; Munk, M.H. Short- and long-term effects of cholinergic modulation on gamma oscillations and response synchronization in the visual cortex. J. Neurosci. 2004, 24, 10369-10378.
70. Chintoh, A.; Fulton, J.; Koziel, N.; Aziz, M.; Sud, M.; Yeomans, J.S. Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M. Pharmacol. Biochem. Behav. 2003, 76, 53-61.
71. Gholamreza, P.; Pratt, J.A.; Nima, D. Effects of low-dose scopolamine on locomotor activity: No dissociation between cognitive and non-cognitive effects. Neurosci. Res. Commun. 2002, 31, 165-174.
72. Hughes, R.N.; Desmond, C.S.; Fisher, L.C. Room novelty, sex, scopolamine and their interactions as determinants of general activity and rearing, and light Cdark preferences in rats. Behav. Process 2004, 67, 173-181.
73. Carli, M.; Balducci, C.; Millan, M.J.; Bonalumi, P.; Samanin, R. S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Br. J. Clin. Pharmacol. 1999, 128, 1207-1214.
74. Wilson, D.A. Scopolamine enhances generalization between odor representations in rat olfactory cortex. Learn. Memory 2001, 8, 279-285.
75. Higgs, S.; Deacon, R.M.J.; Rawlins, J.N.P. Effects of scopolamine on a novel choice serial reaction time task. Eur. J. Neurosci. 2000, 12, 1781-1788.
76. Sambeth, A.; Riedel, W.; Smits, L.; Blokland, A. Cholinergic drugs affect novel object recognition in rats: Relation with hippocampal EEG? Eur. J. Pharmacol. 2007, 572, 151-159.
77. Zhang, W.W.; Song, M.K.; Cui, Y.Y.; Wang, H.; Zhu, L.; Niu, Y.Y.; Yang, L.M.; Lu, Y.; Chen, H.Z. Differential neuropsychopharmacological influences of naturally occurring tropane alkaloids anisodamine versus scopolamine. Neurosci. Lett. 2008, 443, 241-245.
78. Wang, H.; Lu, Y.; Chen, H.Z. Differentiating effects of anisodamine on cognitive amelioration and peripheral muscarinic side effects induced by pilocarpine in mice. Neurosci. Lett. 2003, 344, 173-176.
79. Xu, Z.P.; Wang, H.; Hou, L.N.; Xia, Z.; Zhu, L.; Chen, H.Z.; Cui, Y.Y. Modulatory effect of anisodamine on airway hyper-reactivity and eosinophilic inflammation in a murine model of allergic asthma. Int. Immunopharmacol. 2011, 11, 260-265.
80. Xu, G.N.; Yang, K.; Xu, Z.P.; Zhu, L.; Hou, L.N.; Qi, H.; Chen, H.Z.; Cui, Y.Y. Protective effects of anisodamine on cigarette smoke extract-induced airway smooth muscle cell proliferation and tracheal contractility. Toxicol. Appl. Pharm. 2012, 262, 70-79.
81. + transients in isolated adult rat ventricular myocytes. Eur. J. Pharmacol. 2002, 439, 21-25.
82. Zhang, S.; Liu, J.; He, L. Anisodamine (654-2) improves impaired cognitive function induced by experimental brain damage. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1995, 17, 254-258.
83. Liu, C.; Shen, F.M.; Le, Y.Y.; Kong, Y.; Liu, X.; Cai, G.J.; Chen, A.F.; Su, D.F. Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor. Crit. Care Med. 2009, 37, 636-641.
84. Zhou, J.X.; Ke, P.; Huan, G.; Shao, B.Z.; Liu, C. Combined treatment with anisodamine and neostigmine inhibits joint inflammation in collagen-induced arthritis mice. CNS Neurosci. Ther. 2014, 20, 186-187.